candesartan

angiotensin II receptor antagonist used mainly for the treatment of hypertension

Wikidata entity: Q415970

C₂₄H₂₀N₆O₃ (P274)


Wikimedia Commons category is Candesartan

Quantities

P4250defined daily dose8
P2067mass440.16

P3780 active ingredient in ... Q47521203 (Atacand) Atacand
P233 canonical SMILES String CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O ???
P373 Commons category String Candesartan ???
P527 has part(s) ... Q627 (nitrogen) nitrogen
P527 has part(s) ... Q623 (carbon) carbon
P366 has use ... Q12140 (medication) medication
P8224 image of molecular model or crystal lattice model CommonsMedia http://commons.wikimedia.org/wiki/Special:FilePath/Candesartan.png ???
P31 instance of ... Q113145171 (type of chemical entity) type of chemical entity
P3493 legal status (medicine) ... Q879952 (boxed warning) boxed warning
P8026 LiverTox likelihood score ... Q83284310 (LiverTox toxicity likelihood category C) LiverTox toxicity likelihood category C
P2175 medical condition treated ... Q41861 (arterial hypertension) arterial hypertension
P2175 medical condition treated ... Q19000661 (congestive heart failure) congestive heart failure
P361 part of ... Q22274463 (response to candesartan) response to candesartan
P129 physically interacts with ... Q2819188 (angiotensin II receptor type 1) angiotensin II receptor type 1
P3489 pregnancy category ... Q3679274 (Australian pregnancy category D) Australian pregnancy category D
P5555 schematic CommonsMedia http://commons.wikimedia.org/wiki/Special:FilePath/Candesartan%20synth%20corrected.svg ???
P769 significant drug interaction ... Q45050 (tenoxicam) tenoxicam
P769 significant drug interaction ... Q186969 (ibuprofen) ibuprofen
P769 significant drug interaction ... Q221520 (triamterene) triamterene
P769 significant drug interaction ... Q244408 (Diclofenac) Diclofenac
P769 significant drug interaction ... Q277785 (perindopril) perindopril
P769 significant drug interaction ... Q347941 (parecoxib) parecoxib
P769 significant drug interaction ... Q409231 (indomethacin) indomethacin
P769 significant drug interaction ... Q412666 (ramipril) ramipril
P769 significant drug interaction ... Q408676 (piroxicam) piroxicam
P769 significant drug interaction ... Q408801 (celecoxib) celecoxib
P769 significant drug interaction ... Q409192 ((RS)-ketoprofen) (RS)-ketoprofen
P769 significant drug interaction ... Q414028 (meloxicam) meloxicam
P769 significant drug interaction ... Q419890 ((±)-flurbiprofen) (±)-flurbiprofen
P769 significant drug interaction ... Q419995 (amiloride) amiloride
P769 significant drug interaction ... Q421119 (captopril) captopril
P769 significant drug interaction ... Q422185 (enalapril) enalapril
P769 significant drug interaction ... Q422188 (spironolactone) spironolactone
P769 significant drug interaction ... Q422665 (trimethoprim) trimethoprim
P769 significant drug interaction ... Q423804 (eplerenone) eplerenone
P769 significant drug interaction ... Q425207 (nabumetone) nabumetone
P769 significant drug interaction ... Q425293 (fosinopril) fosinopril
P769 significant drug interaction ... Q596022 (quinapril) quinapril
P769 significant drug interaction ... Q929420 (trandolapril) trandolapril
P769 significant drug interaction ... Q963093 (sulindac) sulindac
P769 significant drug interaction ... Q1215575 (naproxen) naproxen
P769 significant drug interaction ... Q2465218 ((RS)-etodolac) (RS)-etodolac
P769 significant drug interaction ... Q2555245 ((RS)-fenoprofen) (RS)-fenoprofen
P769 significant drug interaction ... Q47495698 (lisinopril dihydrate) lisinopril dihydrate
P279 subclass of ... Q134856 (carboxylic acid) carboxylic acid
P279 subclass of ... Q193430 (heterocyclic compound) heterocyclic compound
P2868 subject has role ... Q285044 (angiotensin II receptor antagonist) angiotensin II receptor antagonist
P2868 subject has role ... Q575890 (antihypertensive drug) antihypertensive drug
External Ids
P267ATC codeC09CA06
P231CAS Registry Number139481-59-7
P683ChEBI ID3347
P592ChEMBL IDCHEMBL1016
P661ChemSpider ID2445
P715DrugBank IDDB13919
P8494DSSTOX compound identifierDTXCID202725
P3117DSSTox substance IDDTXSID0022725
P232EC number604-138-8
P2566ECHA Substance Infocard ID100.132.654
P646Freebase ID/m/04ntcn
P595Guide to Pharmacology Ligand ID587
P595Guide to Pharmacology Ligand ID6907
P2062HSDB ID7520
P2057Human Metabolome Database IDHMDB0014934
P234InChIInChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)
P235InChIKeyHTQMVQVXFRQIKW-UHFFFAOYSA-N
P665KEGG IDD00522
P665KEGG IDC07468
P7830LiverTox IDCandesartan
P6689MassBank accession IDMSBNK-Athens_Univ-AU213701
P6689MassBank accession IDMSBNK-Athens_Univ-AU213702
P6689MassBank accession IDMSBNK-Athens_Univ-AU213703
P6689MassBank accession IDMSBNK-Athens_Univ-AU213704
P6689MassBank accession IDMSBNK-Athens_Univ-AU213705
P6689MassBank accession IDMSBNK-Athens_Univ-AU213707
P6689MassBank accession IDMSBNK-Athens_Univ-AU213708
P6689MassBank accession IDMSBNK-Athens_Univ-AU213709
P6689MassBank accession IDMSBNK-Athens_Univ-AU213717
P6689MassBank accession IDMSBNK-Athens_Univ-AU213718
P6689MassBank accession IDMSBNK-Athens_Univ-AU213751
P6689MassBank accession IDMSBNK-Athens_Univ-AU213752
P6689MassBank accession IDMSBNK-Athens_Univ-AU213753
P6689MassBank accession IDMSBNK-Athens_Univ-AU213754
P6689MassBank accession IDMSBNK-Athens_Univ-AU213755
P6689MassBank accession IDMSBNK-Eawag-EA280401
P6689MassBank accession IDMSBNK-Eawag-EA280402
P6689MassBank accession IDMSBNK-Eawag-EA280403
P6689MassBank accession IDMSBNK-Eawag-EA280404
P6689MassBank accession IDMSBNK-Eawag-EA280405
P6689MassBank accession IDMSBNK-Eawag-EA280406
P6689MassBank accession IDMSBNK-Eawag-EA280407
P6689MassBank accession IDMSBNK-Eawag-EA280408
P6689MassBank accession IDMSBNK-Eawag-EA280409
P6689MassBank accession IDMSBNK-Eawag-EA280410
P6689MassBank accession IDMSBNK-Eawag-EA280411
P6689MassBank accession IDMSBNK-Eawag-EA280412
P6689MassBank accession IDMSBNK-Eawag-EA280413
P6689MassBank accession IDMSBNK-Eawag-EA280414
P6689MassBank accession IDMSBNK-Eawag-EA280451
P6689MassBank accession IDMSBNK-Eawag-EA280452
P6689MassBank accession IDMSBNK-Eawag-EA280453
P6689MassBank accession IDMSBNK-Eawag-EA280454
P6689MassBank accession IDMSBNK-Eawag-EA280455
P6689MassBank accession IDMSBNK-Eawag-EA280456
P6689MassBank accession IDMSBNK-Eawag-EA280457
P6689MassBank accession IDMSBNK-Eawag-EA280458
P6689MassBank accession IDMSBNK-Eawag-EA280459
P6689MassBank accession IDMSBNK-Eawag-EA280460
P6689MassBank accession IDMSBNK-Eawag-EA280461
P6689MassBank accession IDMSBNK-Eawag-EA280462
P6689MassBank accession IDMSBNK-Eawag-EA280463
P6689MassBank accession IDMSBNK-Eawag-EA280464
P6689MassBank accession IDMSBNK-UFZ-UA007901
P6689MassBank accession IDMSBNK-UFZ-UA007902
P6689MassBank accession IDSM818201
P6689MassBank accession IDSM818251
P10245MedlinePlus drug identifiera601033
P486MeSH descriptor IDC081643
P6366Microsoft Academic ID (discontinued)2780036600
P2115NDF-RT IDN0000148603
P2840NSC number759858
P10283OpenAlex IDC2780036600
P4235PatientsLikeMe treatment IDcandesartan
P11199Probes And Drugs IDPD001315
P662PubChem CID2541
P1579Reaxys registry number6377719
P3345RxNorm CUI214354
P4964SPLASHsplash10-001i-0900000000-aad7b334b76f7066ae1e
P4964SPLASHsplash10-001i-0900000000-bf38bb169df6697bd345
P4964SPLASHsplash10-001i-0900000000-e9298a423fa741683f4d
P4964SPLASHsplash10-001i-0901000000-e42def94ea7acc3e984c
P4964SPLASHsplash10-001i-0901000000-e8293134d3b6edc1cc44
P4964SPLASHsplash10-001i-0902000000-9d8d5d747fc07188bcd6
P4964SPLASHsplash10-001i-0911000000-b335b08ddf551145ef5c
P4964SPLASHsplash10-00kf-0920000000-4eb700bf722035bbc5e6
P4964SPLASHsplash10-03di-0090400000-8977fe66c12ae5daf842
P4964SPLASHsplash10-03di-0090400000-d1a491f53255bc054efe
P4964SPLASHsplash10-03di-0692200000-2d47b15f47b41bdbebed
P4964SPLASHsplash10-03dr-0092200000-c93d18ca0f8aace375e7
P4964SPLASHsplash10-03dr-0192000000-7f13db6e80afed497be0
P4964SPLASHsplash10-03dr-0192000000-e19af79847787e125480
P4964SPLASHsplash10-03k9-0090800000-498c7dbf4edcf24086ae
P4964SPLASHsplash10-03k9-0090800000-8aaa172c9293c5ae972a
P4964SPLASHsplash10-052f-0892000000-aadfb13bbceced2abed1
P4964SPLASHsplash10-052f-0892000000-fbf84d949230e0f7cdcf
P4964SPLASHsplash10-053i-0829800000-75336f6b69959f06951d
P4964SPLASHsplash10-053r-0925000000-b2853a4d3ef881471918
P4964SPLASHsplash10-053r-0934000000-07766836cd4310e3c144
P4964SPLASHsplash10-06rl-0392000000-c3ccc11e70e6108541a5
P4964SPLASHsplash10-08mi-1693300000-e31b853c08a2b3f6b0ab
P4964SPLASHsplash10-0a4i-0009000000-3f09ac2e45a45cf51567
P4964SPLASHsplash10-0a4i-0009000000-dffef5ed5958e9c3aa46
P4964SPLASHsplash10-0a4i-0329000000-5bab9c66bf500046dd03
P4964SPLASHsplash10-0a4i-0429000000-e6666ddaea6b2fec4796
P4964SPLASHsplash10-0a4l-0941000000-960f676aef7b7f30eb65
P4964SPLASHsplash10-0a4l-0982000000-48b2e463d5df0f082d64
P4964SPLASHsplash10-0a4r-0319500000-3993447974e9c0f96e19
P4964SPLASHsplash10-0bu0-0916000000-066da93a95b0b10a64f7
P4964SPLASHsplash10-0ftf-0910000000-0468a1554ab3d27acb6e
P4964SPLASHsplash10-0ftf-0910000000-8a887e64aa26b17819f1
P4964SPLASHsplash10-0006-0910000000-b0e858bc66d29221b761
P4964SPLASHsplash10-0006-0931000000-30b595e099863925404a
P4964SPLASHsplash10-0006-0931000000-f09988e63e0ff1ee7c41
P4964SPLASHsplash10-000i-0000900000-09252e3705ec18f28191
P4964SPLASHsplash10-000i-0000900000-4332e0602a564f2c4578
P4964SPLASHsplash10-000i-0000900000-c0732b3f672bdb0c5cd9
P4964SPLASHsplash10-001i-0900000000-7cd909aa2c285aa2e22b
P2877SureChEMBL ID3938
P2877SureChEMBL ID40832
P2892UMLS CUIC0217087
P2892UMLS CUIC0717550
P11089UniChem compound ID26904
P652UNIIS8Q36MD2XX
P11143WikiProjectMed IDCandesartan

Why not click here or view trends?

log id: 2028749